For The Time Being, The Company’s Stock Appears Priced For Perfection.

What the heck is going on here? More than likely, this move has to do with the anticipation of GW Pharmaceuticals’ filing for a new drug application (NDA) with the Food and Drug Administration (FDA) for Epidiolex very soon. Epidiolex is an oral cannabinoid-based medicine that, in phase 3 clinical trials, generated a statistically significant reduction in seizure frequency for patients with two rare types of childhood-onset epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. GW Pharmaceuticals’ management team has suggested that investors expect an NDA filing by mid-2017, which would signal it’s due any time now.¬† If Epidiolex gets a green light from the FDA, and it’s fortunate enough to expand its label beyond just the two aforementioned rarer types of epilepsy, it could make a run at perhaps $1 billion in peak annual sales.¬†This is why investors are so bullish regarding GW Pharmaceuticals. Still, we’ll need to see if the FDA grants the company a priority review, which would shorten the NDA review period by four months to a six-month process and get Epidiolex to market quickly. Further, an approval is no guarantee for a cannabinoid-based product. Likewise, with the company’s only Marijuana Stocks other approved product (outside the U.S.), Sativex, failing to garner much in the way of sales, there are concerns about GW Pharmaceuticals’ effectiveness in marketing and pricing Epidiolex, if approved. For the time being, the company’s stock appears priced for perfection. Unlike GW Pharmaceuticals, where hope seems to reign supreme, three press releases over the past couple of weeks have been wholly responsible for Aurora Cannabis’ ( NASDAQOTH:ACBFF ) charge higher. In just two weeks, the Canadian medical-cannabis producer and retailer has seen its share price rocket 29% higher.

To read more visit https://www.fool.com/investing/2017/07/26/the-3-hottest-marijuana-stocks-right-now.aspx

Through Diversification Into Horizontal Markets, Singlepoint Is Building Its Portfolio By Acquiring An Interest In Undervalued Subsidiaries, Thereby Providing A Rich, Diversified Holding Base.

CannabisNewsWire Announces Publication Highlighting Investment Opportunities in Cryptocurrency NEW YORK, NY–(Marketwired – Oct 25, 2017) – CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company for the cannabis industry, today announces the publication of an editorial featuring SinglePoint, Inc. ( : SING ), a client of CNW focused on strengthening its position in the marijuana industry through the acquisition of, or investment in, small to mid-sized cannabis companies. The publication, titled, “Bitcoin’s Recent Gains Spell Opportunity for Cryptocurrency Companies,” shines a light on the current demand for alternative investment options. To view the full publication, visit: https://www.cannabisnewswire.com/bitcoins-recent-gains-spell-opportunity-cryptocurrency-companies/ “SinglePoint has entered a period of rapid development aimed at executing on its bitcoin payments solution. The company’s management team noted that a recently announced new round of funding would play a key role in SinglePoint’s efforts to “move very quickly to develop a cryptocurrency solution and continue acquisitions in the cannabis space.” In early August, SinglePoint confirmed ( http://cnw.fm/RPwq4 ) the swiftness of its development efforts by announcing the commencement of development for its in-house solution enabling consumers to ‘obtain bitcoin at any point of sale.’ While this new payment exchange is expected to be particularly Medical marijuana useful to the maturing cannabis sector, its potential applications could extend well beyond the bounds of marijuana. “As SinglePoint noted in a news release, its new product will be ‘a payment service to make instant bitcoin powered purchases possible when all you have is a credit (or debit) card,’ presenting upside for a wide variety of businesses, most notably in high risk markets.” SinglePoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry.

To read more visit http://www.marketwired.com/press-release/cannabisnewswire-announces-publication-highlighting-investment-opportunities-cryptocurrency-pinksheets-sing-2238295.htm